Formulation 

Valcyte is available as a 450 mg tablet for oral administration. Each tablet contains 496.3 mg of valganciclovir HCI (corresponding to 450 mg of valganciclovir), and the inactive ingredients microcrystalline cellulose, povidone K-30, crospovidone, and stearic acid. The film-coat applied to the tablets contains Opadry Pink®.¹

Valcyte is supplied in bottles of 60 tablets (NDC 0004-0038-22).¹

  Safety Information

Reference:

⁴ Valcyte® [product information]. Nutley, NJ: Roche Laboratories Inc.; January 2006.